Elevation Oncology (ELEV) SC 13G Elevation Oncology / ExodusPoint Capital Management ownership change

EXHIBIT 99.1

JOINT FILING AGREEMENT

PURSUANT TO RULE 13d-1(k)

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

Dated: June 9, 2023
	ExodusPoint Capital Management, LP
	By:	/s/   Brendan Kalb
	Name:	Brendan Kalb
	Title:	Authorized Signatory
	ExodusPoint Capital Partners GP, LLC
	By:	/s/   Brendan Kalb
	Name:	Brendan Kalb
	Title:	Authorized Signatory
	Michael Gelband
	By:	/s/   Michael Gelband
	Hyung Lee
	By:	/s/   Hyung Lee